Table 3 Comparison between Ebstein anomaly patient groups with and without LGE
LGE positive (N = 10) | LGE negative (N = 34) | P | |
|---|---|---|---|
Age, yrs | 40.4 ± 16.1 | 31.6 ± 15.8 | 0.131 |
Male (n, %) | 6 (60) | 12 (35.3) | 0.273 |
Heart rate, bpm | 78.1 ± 7.8 | 84.7 ± 13.4 | 0.147 |
BMI, kg/m2 | 22.8 ± 4.8 | 21.4 ± 4.8 | 0.428 |
NYHA classification | 2.3 ± 0.5 | 1.8 ± 0.5 | 0.011 |
SO2 at rest, % | 95.1 ± 2.6 | 97.1 ± 2.5 | 0.042 |
Severe TR (n, %) | 8 (80.0) | 24 (70.6) | 0.557 |
ASD/PFO (n, %) | 7 (70.0) | 22 (64.7) | 1.000 |
W-P-W (n, %) | 1 (10.0) | 5 (14.7) | 0.950 |
QRS width, ms | 114.2 ± 19.0 | 113.5 ± 15.2 | 0.910 |
LV EDV index, ml/m2 | 62.5 [12.6] | 71.1 [21.2] | 0.233 |
LV ESV index, ml/m2 | 30.6 [5.6] | 33.7 [15.3] | 0.537 |
LV EF, % | 49.2 ± 10.5 | 53.7 ± 6.7 | 0.106 |
fRV EDV index, ml/m2 | 194.5 [87.7] | 127.4 [57.4] | 0.007 |
fRV ESV index, ml/m2 | 123.6 [64.4] | 67.4 [28.7] | < 0.001 |
fRV EF, % | 40.1 ± 12.7 | 45.0 ± 11.1 | 0.251 |
aRV EDV index, ml/m2 | 107.6 ± 76.16 | 62.4 ± 35.9 | 0.011 |
Total R/L-Volume-Index | 6.9 ± 3.4 | 3.5 ± 1.7 | 0.011 |
SI | 1.1 ± 0.4 | 0.9 ± 0.4 | 0.195 |